Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
After blocking in 5% skimmed milk powder for 2 hours at room temperature, the samples were incubated overnight at 4C with primary antibodies, including ERK1/2 (#9102), p-ERK1/2 (#9101), JNK1/2 (#9252), p-JNK (#9251), p38 MAPK (#9212), and p-p38 MAPK (#9211), which were obtained from Cell Signaling Technology (Beverly, MA, USA), as well as VEGF-a (sc-7269) and Tubulin (sc-8035), which were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA)
NEJM 2011;365:15971604: 10.1056/NEJMoa1105816
Used to reconstitute this lyophilised vial before laboratory preparation
Science 176 , 309310 (1972)
US$ 20.27
US$ 29.00
US$ 20.43
US$ 24.21
US$ 21.17
US$ 26.22
